A potential COVID-19 vaccine has achieved a "major milestone" in moving toward human clinical trials, according to researchers in Saskatchewan. The University of Saskatchewan's Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) said Monday that a vaccine candidate it has developed has proven to be "highly effective" in pre-clinical…